Nasdaq, Inc. (NDAQ - Free Report) has signed an agreement with Stifel Financial Corp. to develop a new alternative trading system known as the Stifel Crossing Platform (STFX).
Nasdaq’s Market Technology will be used by Stifel in developing the new Alternative Trading System, which is projected to go live next month. STFX will provide access to a unique source of liquidity to the firm’s 3,500 institutional clients.
St. Louis, MO-based Stifel is a financial services firm, which offers brokerage, trading, investment banking, investment advisory services to individual investors, professional money managers, businesses and municipalities through more than 390 locations across the nation. It is an active daily market maker in more than 4,000 stocks across all sectors and traded 6.6 billion shares in 2019.
With this partnership, Nasdaq will provide Stifel with a high-performing technology and a scalable infrastructure solution to boost the latter’s efficiency, and enable it to innovate, compete and grow offerings and services.
The newly-launched STFX will boost the trading capabilities of Stifel and provide unique flexibility and alliance of new technologies apart from fulfilling all regulatory requirements.
Shares of this Zacks Rank #2 (Buy) stock have rallied 26.9% in the past year, outperforming the industry’s decline of 20.9%. Solid fundamentals will help the stock move higher than the industry.
Other Stocks to Consider
Investors interested in the same industry can look at other top-ranked stocks like CME Group (CME - Free Report) , Cboe Global Markets (CBOE - Free Report) and MarketAxess Holdings (MKTX - Free Report) .
MarketAxess operates an electronic trading platform that enables fixed-income market participants to trade corporate bonds and other types of fixed-income instruments worldwide. The company delivered a positive surprise of 3.70% in the last reported quarter. It sports Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
CME operates contract markets for the trading of futures and options on futures contracts worldwide. The company delivered a 4.48% positive surprise in the last reported quarter. The company currently carries a Zacks Rank #2.
Cboe Global operates as an options exchange in the United States. The company delivered a positive surprise of 7.14% in the last reported quarter. The company holds a Zacks Rank #2, currently.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Nasdaq, Inc. (NDAQ - Free Report) has signed an agreement with Stifel Financial Corp. to develop a new alternative trading system known as the Stifel Crossing Platform (STFX).
Nasdaq’s Market Technology will be used by Stifel in developing the new Alternative Trading System, which is projected to go live next month. STFX will provide access to a unique source of liquidity to the firm’s 3,500 institutional clients.
St. Louis, MO-based Stifel is a financial services firm, which offers brokerage, trading, investment banking, investment advisory services to individual investors, professional money managers, businesses and municipalities through more than 390 locations across the nation. It is an active daily market maker in more than 4,000 stocks across all sectors and traded 6.6 billion shares in 2019.
With this partnership, Nasdaq will provide Stifel with a high-performing technology and a scalable infrastructure solution to boost the latter’s efficiency, and enable it to innovate, compete and grow offerings and services.
The newly-launched STFX will boost the trading capabilities of Stifel and provide unique flexibility and alliance of new technologies apart from fulfilling all regulatory requirements.
Shares of this Zacks Rank #2 (Buy) stock have rallied 26.9% in the past year, outperforming the industry’s decline of 20.9%. Solid fundamentals will help the stock move higher than the industry.
Other Stocks to Consider
Investors interested in the same industry can look at other top-ranked stocks like CME Group (CME - Free Report) , Cboe Global Markets (CBOE - Free Report) and MarketAxess Holdings (MKTX - Free Report) .
MarketAxess operates an electronic trading platform that enables fixed-income market participants to trade corporate bonds and other types of fixed-income instruments worldwide. The company delivered a positive surprise of 3.70% in the last reported quarter. It sports Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
CME operates contract markets for the trading of futures and options on futures contracts worldwide. The company delivered a 4.48% positive surprise in the last reported quarter. The company currently carries a Zacks Rank #2.
Cboe Global operates as an options exchange in the United States. The company delivered a positive surprise of 7.14% in the last reported quarter. The company holds a Zacks Rank #2, currently.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on CME - FREE
Get the latest research report on NDAQ - FREE
Get the latest research report on CBOE - FREE
Get the latest research report on MKTX - FREE